CONFIDENTIAL TO BOARD MEMBERS ONLY
NEW ZEALAND BLOOD SERVICE
Minutes – NZBS Board Meeting
Minutes of the NZBS Board
Meeting held:
By Video Conference
In at endance:
Mr David Chamberlain (Chair)
Dr Jackie Blue (Deputy Chair)
Dr Bart Baker
Ms Edie Moke
Dr Paula Martin
Ms Fiona Pimm
Mr Ray Lind
Apologies:
Mr John Harrison (Director Finance & Corporate Services)
Management:
Ms Sam Cliffe (Chief Executive)
Board Secretariat:
Vanessa Siddins (Board Secretary)
Date:
28 May 2020
9.00am
BOARD ONLY TIME
Board only time commenced at 9.05am with D Chamberlain noting J Harrison’s apologies due to the death of his mother.
The Chair then welcomed Edie Moke to her first NZBS Board meeting.
D Chamberlain advised that a key part of the Board meeting was the financials and that the organisation had been
unsuccessful in the budget round for Covid-19 related losses. He further noted that S Clif e had writ en to Minister Henare’s
office and that they were in dialogue. There was concern raised around the morale of the Executive team over the lack of
success in the budget round as the Ministry were adamant there was no more money. D Chamberlain responded that S
Clif e and her team were professional and although they were surprised with the decision, the mood has remained positive.
D Chamberlain noted that there had been a phishing incident whereby an email was sent to payrol and the instruction
was actioned. This meant that a staf member’s bank account was updated in the payrol system to a fraudulent account.
The BNZ recognised that the account was suspicious and blocked the payment before contacting J Harrison. D
Chamberlain advised that this was more a risk around the process and had asked J Harrison to report back to the Board
on how the controls around establishing a new bank account for payrol had been strengthened.
D Chamberlain highlighted that a property had been identified in Hamilton that the organisation would potential y like to
take a long term lease on and that S Clif e would provide further information on this.
Further discussion fol owed on the lack of understanding of the organisation’s financials by the Ministry and if any further
communication was needed with the Minister of Health.
S Cliffe joined the meeting at 9.20am.
ITEM 1.0 APOLOGIES
J Harrison gave his apologies for this meeting.
NZBS Board Minutes – 28 May 2020
Page
1 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
ITEM 2.0 INTERESTS REGISTER
2.1
Updates to the Interest Register
E Moke undertook to provide updates to her interest register for West Coast DHB and Ngā Taonga Sound & Vision.
P Martin had provided details of her new role with the Auditor General before the meeting.
R Lind advised that he is no longer a board member of Health Workforce.
2.2
Declarations of Conflicts of Interest for this Agenda
As a DHB Board member, E Moke wil abstain for voting on item 6.6 DHB Price Rebate.
ITEM 3.0 MINUTES OF PREVIOUS MEETING/ACTIONS REPORT
3.1
Confirmation of Minutes – 28 March 2019
Motion:
The presented minutes of the 26 March 2020 NZBS Board meeting were accepted as a true and correct
record of that meeting.
Motion by:
F Pimm
Seconded by: P Martin
Carried:
Al present in favour
3.3
Schedule of Outstanding Action Items from Previous Meetings
The status of all action items as outlined in agenda item 3.3 were noted.
The fol owing action item was discussed:
Item 2.6 S Cliffe noted it was worth re-thinking about horizon scanning post Covid.
3.3
Matters Arising (Not Covered Elsewhere)
No mat ers arising.
ITEM 4.0 CHAIRMAN’S REPORT
D Chamberlain advised there was nothing to report.
ITEM 5.0 CEO’s REPORT
S Cliffe presented the CEO’s report and during discussion the fol owing mat ers were specifical y highlighted:
After a video meeting with Minister Henare on 20 April, he had asked to be kept informed with regard to our budget bid for
Covid financial recovery monies and had expressed surprise and disappointment with the results. The Covid related
exposure is $8.2m. The second issue is the $15m infrastructure need via an equity injection. It’s hard to get the Ministry
to understand if we can’t invest we wil end up moving away from self-reliance of Ig product to a high dependence on
commercial Ig product. S Cliffe is optimistic around the funding and will keep pursuing this as the alternative is undesirable.
She noted that the Ministry had offered the organisation a letter of comfort to our bank and our potential new landlord in
Hamilton. If we had to recoup the earnings impact ourselves, the price increase to DHBs would be 9-10% range for
2020/21.
NZBS Board Minutes – 28 May 2020
Page
2 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
There was further discussion around the escalation process and communications with Minister Henare and the Minister of
Health. She is comfortable that Minister Henare will be able to put our case forward clearly to Minister Clark.
P Martin queried if there had been any clarification around funding for the organ donation national agency? S Cliffe
responded that the Ministry haven’t been able to provide this information to date and she is hoping they wil have answers
in the near future.
The DHBs won’t like a 10% price increase but we would need to do this if it’s our only option to maintain financial stability.
The issue is the demand for Ig, we know our utilisation is trending upwards and we would put the country’s self-reliance
into a steady decline if we can’t meet ongoing demand from NZ sourced plasma.
S Cliffe advised that she will be looking at ef iciencies within the organisation, however is not proposing any layoffs at this
time. For example, travel costs should be significantly reduced for the foreseeable future. Only managers with large
dispersed teams wil be approved to travel.
There was further discussion around the organ donation agency funding cut of $250k but it was not clear what it was cut
from. The question was raised of how long the Board will let this lack of clarity around funding go on for? D Chamberlain
advised that if the time comes that S Cliffe doesn’t feel like she’s making progress, he wil take this up with the Minister. S
Clif e noted that there are short, medium and long term implications around this but she is more concerned about the long
term implications. It erodes the Blood Service’s ability to supply products for New Zealand. With no additional funding, by
late 2022 we wil be obligated to be out of the Tauranga site and would have to close the donor site with the same
implications in our Palmerston North site. By the end of September, we would potential y be breaching two banking
covenants and would not be able to build additional centres in Auckland. We wil need to make a decision how to frame
the budget over next four years.
71 GSR is under a major refurbishment and is an aging 20 year old facility. We have completed stage 2 upstairs and stage
3 is al our manufacturing, laboratory and logistics space. S Cliffe felt that the saving grace is the organisation was in great
shape and her role is to ensure the organisation’s sustainability. The Ministry don’t understand that we absorb a lot of
costs especially for our softer services such as clinical oversight and therapeutic services. We would have to re-cost and
it won’t be well received by the DHBs. It was noted that Sarah Turner, Deputy Director-General. Of ice of the Director-
General has been at ending the meetings with the Ministry and was reporting back to Ashley Bloomfield. S Cliffe will
contact Ashley directly if we don’t get a good response.
E Moke noted that sometimes organisations aren’t considered as important as they aren’t seen as front facing. How does
the organisation rate in terms of visibility and was it a strategic approach to fly below radar? S Clif e responded that the
profile is much higher than it had been and that we are not under the radar for people that want to donate. It’s not easy to
get free publicity as good news stories don’t always sel . If we raise the profile too high, we can end up with a queue at the
door for a fortnight then it goes away. We have World Blood Donor Day next month which wil give us some good publicity.
There was further discussion around the need to get this resolved before the election lockdown.
S Cliffe recal ed that in the first week of lock down there were some anxieties with front line staf before the organisation
made the decision to buy its own PPE. We also made the decision to buy more Privigen which should give us another 12-
18 months before we run out of stock. S Clif e is proud of the organisation and felt it had performed real y wel . She is
having Skype meetings with team leaders and the teams have fed back that they feel safe and that communication has
been good with the EOC team doing a great job. We have not failed to supply and in an environment where there are very
few flights it was amazing. Col ections are good and staff appear to be feeling ok. There wil be issues around pay restraint
which wil cause some angst. Staff have been kept informed about the State Services Commission guidelines and the
organisation is aware that S Cliffe had taken a pay cut. Our nurses have similar pay to NZNO and we match DHB
settlements. We had already set led with ASMS and Apex this year.
R Lind of ered to reduce his Board fees by 20%. D Chamberlain felt it was for individual Board members to decide if they
wanted to reduce their fees and highlighted that Board fees haven’t changed since 2009 and didn’t want to encourage the
Board one way or another. E Moke felt it appropriate to agree to a 20% cut which would be a signal of support to staf .
S Clif e noted that she had been clear with staff that they were not going to take a pay cut and the organisation would
honour al commitments.
NZBS Board Minutes – 28 May 2020
Page
3 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
a risk in cost over runs if we sign. There was further discussion around who would be liable if the standards were elevated
in the future and there are further requirements. D Chamberlain noted that it takes a long time to bring in any changes so
can’t see it changing in the next three years. It was further noted the issue with hollow core flooring which is also being
strengthened separately to the planned seismic strengthening works.
B Baker noted there is quite a generous contingency, which perhaps would al ay concerns? D Chamberlain responded
that he had wanted to raise the concerns, but feels comfortable that the risks have been accurately assessed. S Cliffe
added that J Harrison is not present today, but would be happy to put a cal into Buddle Findlay if the Board wanted
clarification or had other questions. D Chamberlain felt the Board should run with J Harrison’s assessment as he has done
a great job get ing Dilworth to finance this while maintaining good relationship.
F Pimm thanked D Chamberlain for identifying this and noted that It was important it was minuted that the Board accepted
the situation.
It was noted that the Board were happy to have the Chair and Deputy Chair use electronic signatures for any signing
required for this meeting.
Motion:
The NZBS Board reviewed the
Deed recording Agreement regarding the Seismic Strengthening Works
(the Deed) and approved the execution of the Deed with the Chair and Deputy Chair to execute the Deed
on behalf of the New Zealand Blood Service.
Motion by:
R Lind
Seconded by: B Baker
Carried:
Al present in favour
6.3
Wel ington Donor Centre Lease Renewal
S Cliffe noted that the Board were already aware the Wel ington site was not an ideal building. The Executive had just
approved updates to the air-conditioning system to improve it. The site is not ideal, but for now it wil be renewed for a
further period. This is a DHB site on the hospital campus.
Motion: The Board approved the rent review associated with the premises at 7 Hospital Road, Newtown, Wel ington
wherein the parties agree a new annual rental of S.9 (2) (b) (ii) with ef ect from 1 March 2020 and nominated the
Chair and Deputy Chair to sign the Agreement Fixing Rent on Review and Acknowledgement of Lease Renewal
document on behalf of the New Zealand Blood Service.
Motion by:
P Martin
Seconded by: F Pimm
Carried:
Al present in favour
6.4
Manukau Donor Centre Lease Extension
S Cliffe noted this is another site that is not ideal and we are extending the lease year by year. However, we do need to
put some money in to improve it with plans to increase the plasma collection capability. It was clarified that there was no
additional rent increase. The landlord is doing the improvements work and this wil be incorporated in the next lease
agreement. Current arrangements are rol ing over on the same terms and conditions.
Motion:
The Board approved the Let er of Term Extension offer from the landlord, Investments of Hope, and
authorise the Chief Executive Of icer to sign the letter on behalf of the New Zealand Blood Service.
Motion by:
B Baker
Seconded by: F Pimm
Carried:
Al present in favour
NZBS Board Minutes – 28 May 2020
Page
6 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
6.5
Westpac Banking Facilities Rol over
S Cliffe advised that this paper is asking to extend the MOCL from 30 June 2021 to 30 June to 2023. D Chamberlain
explained that this is essential y extending the timeframes.
Motion:
The Board approved the increase in MOCL facility arrangements as of ered by Westpac in its 5 May 2020
Offer let er and authorised the Chairman to formal y execute the acceptance of the Of er let er on behalf
of the New Zealand Blood Service.
Motion by:
J Blue
Seconded by: E Moke
Carried:
Al present in favour
6.6
2019/20 Price Rebate to DHBs recommendation
Motion:
The NZBS Board formal y:
Noted;
in accordance with the requirements of the Financial Guidelines policy a DHB price
rebate assessment for the 2019/20 financial year has been undertaken,
Endorsed;
the assessment recommendation that no DHB price rebate be declared for the
financial year ended 30 June 2020,
and Requested; the Chief Executive Of icer communicate the Board’s decision to the Lead DHB CEO
as the nominated representative of the DHB sector on mat ers NZBS.
Motion by:
R Lind
Seconded by: F Pimm
Carried:
Al present in favour (E Moke abstained from voting)
6.7
Deed of Indemnity – Legal refresh and Issue to new Board Member
S Clif e advised that the Deed of Indemnity had been refreshed and updated to more recent and current thinking. The track
changes in the document had been made by Buddle Findlay. If this updated Deed of Indemnity is approved, it will be
issued to al Board members.
D Chamberlain highlighted that item 1.1 on page 2 refers to acting in good faith with reasonable care. He had looked at
the legislation and it looked to be a reasonable addition.
Motion:
The Board reviewed the updated Deed of Indemnity stemming from the review as per the Buddle
Findlay marked- up template. The Board approved the adoption of the updated Deed of Indemnity and
authorised the issue of the new Deed to;
1. New Board member Edie Moke and to;
2. Upgrade the Deed of Indemnity for the other six Board members so that al Board members
are provided equal protection under the refreshed Deed of Indemnity.
Motion by:
B Baker
Seconded by: P Martin
Carried:
Al present in favour
6.8
Hamilton Donor Centre
S Clif e reminded the Board that we are vacating our Hamilton site by the end of 2022 and that after a complex review
process it had been decided that we would no longer be manufacturing in the Waikato. The team have been out and had
a look at sites and found an ideal space, five minutes’ walk from town. It does require extending, however the property
owner S.9 (2) (b) (ii) are keen to do this underpinned by a reasonably long term rental agreement. The rent would
be a considerable increase on what we are paying now. Today the request is for agreement to enter into a non-binding
NZBS Board Minutes – 28 May 2020
Page
7 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
agreement to progress a business case with a more detailed planning phase, which would come back to the Board for
final sign of . The document has been reviewed by D Chamberlain and our lawyers.
Motion:
The Board approved completion of the due diligence process to enable a ful business case to be
prepared for Board consideration. The Board delegated authority to the CEO to enter into a non-
binding agreement with S.9 (2) (b) (ii)
Limited to progress more detailed planning
for this site. A further paper wil be brought back to the board with a final design and lease for approval
at a later date.
Motion by:
R Lind
Seconded by: J Blue
Carried:
Al present in favour
The meeting broke for lunch between 12.30-1.00pm.
ITEM 7.0 DISCUSSION PAPERS
7.1
PRESENTATION: Ernst & Young national agency for organ donation
D Chamberlain welcomed Stephen McKernan, Luke Wil iams and Dominique Squires-Newby from Ernst & Young who
joined the meeting at 1.00pm by video conference.
S Cliffe had good discussions with L Williams and D Squires-Newby yesterday and whilst we haven’t ended up exactly
where we thought we might, a good deal of progress had been made. There wil be some more refining by the end of June,
then a costing piece of work wil be done.
L Williams recapped that back at the last session in February, the Board saw the project plan and key milestones. Since
that time Covid-19 had disrupted the timing, but they had been working with P Martin, S Cliffe and the working group.
There was a good session on 23 April with the working group including possible next steps.
S Cliffe noted that it was important for P Martin, J Blue and B Baker to hear back from the rest of the Board members on
how they think it’s looking and if it starting to make sense. P Martin commented that the Board needed to understand how
the work that EY has done came about.
F Pimm commented that the presentation in the Board papers made sense. It was unclear what the Ministry’s expectations
were, how the national agency would be resourced and could we be enabled to do it. D Chamberlain added that put ing
the money aside, the objectives on page 79 were the first aspect that need to be agreed. P Martin reminded the Board
that we were handed this with no clarity on roles and objectives, essential y finishing the policy work that the Ministry never
did. S Cliffe felt it should be more of a discussion rather than agree details today. More broadly, is the rational explained
enough around what the agency is for and what kind of agency it wil be for the sector. If this is better, how will it be
dif erent? It’s an aspirational list at the moment and we wil need to refine it down at some stage. Is this something we feel
that we can take out to key stakeholders over the next month or two?
R Lind thought it was a stunning piece of work and agreed with objectives that have been set and highlighted at this time
there was an appetite for improved population outcomes. This could be an investment opportunity for the Government.
Should we produce a half page paper for the Minister on how to improve population outcomes with return on financial
investment?
S McKernan noted that this is a key priority for the Minister of Health and decisions had been made at the highest level
with a desire to enhance the service. Gaps in the current system need to be identified, with those that NZBOS can fill made
clear. He agreed that there is a very strong theme in the sector on leading a national response. We are at an important
junction with both organ donation and where the sector is at with this activity. D Chamberlain asked what improving access
to organ donation and transplantation services means? Minimising waiting times for potential organ recipients? B Baker
highlighted that the interaction with other services is the dif icult bit, it’s the interaction, monitoring etc, get ing feedback
from the sector.
NZBS Board Minutes – 28 May 2020
Page
8 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
S Cliffe wondered whether this is being aspirational enough, just describing what the agency can do rather than what the
agency can influence or do over time. If we want to be the agency that pul s everything together, we have to state that in
our objectives up front. We’ve had this debate a lot in the working group, the agency would be the thing that breathes life
into what we want to do rather than what the system wants.
R Lind highlighted that there had been a consensus that organ donation should come to the Blood
Service because Ministers admired the Blood Service’s ability to work across the DHBs. It ought to look like the Blood
Service, a national provider with operational and clinical governance. B Baker said we need to be part of a joined up
system, there is no point in get ing organs if there is nowhere to put them. S Clif e added that good robust clinical
governance would give us a good foundation.
The objectives are pret y much lifted from the National Strategy. R Lind gave the example that when Whangarei Hospital
had issues, NZBS were seen as the authority and we should aspire to be the same in the organ area. P Martin agreed
that the agency should produce information on how the system is performing. S McKernan highlighted the need for
informing DHBs around capacity planning, forecasting and providing some level of growth. There is no reason why NZBOS
couldn’t do that in a more informed manner. B Baker noted a national view and future planning was critical and agreed
that the organisation should be aspirational.
P Martin was thinking this is an agency about leadership and driving change. The agency would not take over surgery,
however we can work with DHBs on data and analytics.
D Chamberlain queried the aspect of developing a register? If we have a register, someone is going to have to work out a
business case. P Martin saw that as policy function and that there needs to be discussion around the ef ectiveness of
registers as it was only included because it was in the National Strategy.
S McKernan noted that from his perspective the Minister had made a decision and the Ministry will prioritise funding where
compel ing cases are made. Providing information to the Ministers/Ministry is key to strengthen national prevention
initiatives. The organisation would need to have discussions with the Ministry sooner rather than later.
E Moke commented that if the organisation’s aspiration is to have a world class organ donation service, is the current
system broken and how do we know that, so that we know when we have done something about it? P Martin responded
that it is not broken but far from ideal. This work started in 2015 with a review of organ donation, transplantation and a
strategy then legislation. Part of strategy national agency recommended a national agency for organ donation. Therefore,
we are trying to work out now what the national agency wil be doing.
D Chamberlain asked if the Board should draw a document together and start a consultation with the Ministry? S Cliffe felt
that we are at the stage before that and the recommendation is to now hand back to EY as they have now heard feedback
from the Board and had some more questions answered. S Cliffe would like to see this document at a draft stage that we
can share with the Ministry and stakeholders. S Clif e felt we need to start with good governance, bed ODNZ in place and
make sure that service levels do not drop.
L Williams found the conversation today really helpful. There had been a compelling case made for the establishment of
a national agency and now the need is for a compel ing case of what that agency can do. There should be an element of
fantastic ideas, a prioritised list and how the agency would make the money work best. EY will continue to col aborate on
this with the working group and P Martin. There was further discussion around making budget bids, how much the agency
would cost to run and how much the enhancements might cost as not everything can be done from day one.
S McKernan left the meeting at 2.08pm.
S Clif e noted that there was no full board meeting until the end of August. She will pick this up with L Williams early next
week to talk in more detail including working out who is doing what and timeframes. It was proposed to keep the working
group going with another session with L Williams and D Squires-Newby in 3-4 week’s time.
D Chamberlain thanked L Williams and Dominque for al the work done to date and look forward to seeing it progress.
The Chair noted that the Board had received and reviewed the report.
ITEM 8
MONTHLY/REGULAR REPORTS
8.1
Director Finance Report – Financial Performance – 10 months to 30 April 2020
E Moke noted that she wil ar ange to spend some time with J Harrison to fill in some of her knowledge gaps. S Cliffe
confirmed that J Harrison would be happy to explain the cost model to E Moke.
NZBS Board Minutes – 28 May 2020
Page
9 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
D Chamberlain highlighted that for clarity, the Australian/New Zealand exchange rate made our result look bet er than it
was. S Clif e noted that nearly $3m had been spent on Privigen, PPE gear, intensive cleaning of sites and donor hosts.
Motion:
The Board received and noted the Directors Finance report
Motion by:
B baker
Seconded by: J Blue
Carried:
Al present in favour
8.2
Q3 Organisation Health & Safety Report
F Pimm congratulated management on achieving 83% take up for flu vaccinations. S Clif e added that this was nearly 20%
higher than last year and would like to maintain that level in the future.
It was noted that the accident where a staf member made a u-turn was not one of our drivers, it was a member of the
collections team.
Motion:
The Q3 Organisation Health & Safety Report was received and noted
Motion by:
F Pimm
Seconded by: J Blue
Carried:
Al present in favour
8.3
Q3 Contracts & Leases Register
The Contracts & Leases Register was received and noted by the Chair.
8.4
Q3 Statement of Performance Monitoring Report
D Chamberlain noted that the dates were awry on page 4 of the report (pg 114). B Baker highlighted that we hadn’t
“Achieved” on 2.4 Haemovigilance reporting timeframe and S Cliffe noted that the new Clinical Surveil ance Manager wil
manage this report going forward. It was further noted that there had been concerns over failure to supply during lockdown
with a lack of flights, particularly from Wel ington to Christchurch. We were also having dif iculties get ing plasma to
Melbourne.
S Clif e explained that we wil send 80 tonnes of plasma to CSL this year and 110 tonnes next year. It is sent twice a week
from Auckland and Christchurch with Christchurch being the issue.
The Statement of Performance Monitoring Report was received and noted by the Chair.
8.5
Q3 Board Expenditure Overview
The Q3 Board Expenditure Overview was received and noted by the Chair.
8.6
Q3 Cybersecurity Report
S Cliffe advised that she had met with the Head of Security at Datacom yesterday. The number of cyber-at acks worldwide
has increased in light of COVID-19. Within this organisation there had been a fraudulent email sent to the NZBS HR
Director just before the pay run. Unfortunately, S.9 (2) (a) bank account was then changed to a fraudulent account. However,
the bank had a watch on that account and the monies were not transferred. Audit NZ had been advised of this incident.
The organisation needs to up its alertness levels as it had the potential to be a serious incident if the monies had not been
quickly recovered. This mat er was discussed in Board Only time before the meeting.
NZBS Board Minutes – 28 May 2020
Page
10 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
Motion:
The Q3 cybersecurity report was received and noted by Board
Motion by:
E Moke
Seconded by: J Blue
Carried:
Al present in favour
ITEM 9
INFORMATION PAPER
9.1
2018/19 Year in Review
S Cliffe presented the foreword to the 2019/20 Annual Report which will be published in September. D Chamberlain
advised that if any of the Board wanted to suggest changes, email S Clif e with track changes in the first instance. V
Siddins sent the Word version to the Board during the break.
9.2
Procurement Policy
D Chamberlain noted that this paper was useful for Board to read, but it didn’t need to be discussed.
ITEM 10 Correspondence
10.1
Letter from SSC – Pay Restraint in the Public Sector – 28 April 2020
The let er received from the SSC dated 28 April 2020 was noted by the Board.
10.2
MoH letter – Cathryn Lancaster end of Board Tenure - 27 April 2020
The letter from MoH dated 27 April 2020 was noted by the Board.
10.3
MoH letter – Edie Moke Board appointment - 28 April 2020
The letter from MoH dated 27 April 2020 was noted by the Board.
10.4
Letter of Expectation 2020/21
S Cliffe
noted it was the same document as the draft earlier this year. It was going to be difficult to meet given the budgets.
ITEM 11 General Business
S Clif e advised that the organisation had been of ered an extension until September for the Statement of Intent and
Statement of Expectation. They had been completed and ready to go, but now may need a fairly serious re-write.
S Clif e has been involved in conversations around the Health Sector review. It has been delivered to the Minister and
received by Cabinet. Details have not been shared yet, however we have been kept in the loop around process. The
Director General is establishing a timeframe of a number of years. If the timeframe is going to be a number of years, we
may not see changes in the very near term.
F Pimm queried if there had been any response around the Ministry’s process of Catherine Lancaster’s tenure ending. D
Chamberlain advised that there had been an apology email that went from the Minister’s Office to Catherine. There had
been a lack of communication between the Minister’s of ice and the Ministry.
S Clif e noted that she would update the Board after her video conference with the Ministry on 29 May 2020.
ITEM 12 Board Matters
12.1
Board Work Programme and Calendar
The NZBS Board Work Programme was noted by the Board.
12.2
Board Member Tenure Timetable
The Board Member Tenure Timetable was noted by the Board.
NZBS Board Minutes – 28 May 2020
Page
11 of
12
CONFIDENTIAL TO BOARD MEMBERS ONLY
ITEM 13 Next Meeting
13.1
The next Board meeting is a video conference on the 2019/20 financial results scheduled for Thursday, 30
July, commencing at 9.30am
Close of Meeting: The meeting closed at 2.50pm.
Certified as a true and correct record:
________________________________
David Chamberlain – Board Chair
NZBS Board Minutes – 28 May 2020
Page
12 of
12
